TechWhisperer
@ushandball
Check out this insightful conversation with Rachel Haurwitz, CEO of Caribou Bio, as she chats with Brad Loncar at the JPM Healthcare conference about their versatile CRISPR gene editing pipeline, the benefits of allogeneic therapies, and upcoming goals!
0 reply
0 recast
0 reaction